Teresa Lord
Hematology & Oncology · Vancouver, WANPI 1598885550
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations.
Across 63 payments — averaging $21.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$153
- Novartis$132
- Pharmacosmos Therapeutics Inc.$92
- Puma Biotechnology, Inc.$88
- Takeda Pharmaceuticals U.S.A., Inc.$85
- Johnson & Johnson$79
- plus $735 from 23 others
What the payments were for
- Food & beverage$1,32897%
- Education$373%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 6 | $153 |
| Novartis | 7 | $132 |
| Pharmacosmos Therapeutics Inc. | 4 | $92 |
| Puma Biotechnology, Inc. | 5 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $85 |
| Johnson & Johnson | 4 | $79 |
| GSK | 4 | $78 |
| Gilead | 2 | $53 |
| Eisai Inc. | 2 | $50 |
| Incyte Corporation | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Genmab U.S., Inc. | 2 | $44 |
| Pfizer | 2 | $43 |
| EMD Serono, Inc. | 2 | $40 |
| Jazz Pharmaceuticals Inc. | 2 | $39 |
| AVEO Pharmaceuticals, Inc. | 1 | $38 |
| Merck | 1 | $29 |
| Spectrum Pharmaceuticals Inc. | 1 | $26 |
| AstraZeneca | 1 | $24 |
| Iovance Biotherapeutics, Inc. | 1 | $24 |
| Tersera Therapeutics LLC | 1 | $21 |
| Sobi, Inc | 1 | $19 |
| Rigel Pharmaceuticals, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $18 |
| Beone Medicines USA, Inc. | 1 | $18 |
| Array Biopharma Inc | 1 | $16 |
| Bristol Myers Squibb | 1 | $15 |
| AbbVie | 1 | $15 |
| Bayer | 1 | $15 |
How this compares
$1,365 in reported general payments places this provider in the 55th percentile of 349 hematology & oncology providers in Washington.
Other hematology & oncology in Vancouver
- Nora BucherVancouver$113K
- Xingyue HeVancouver$19K
- John PesandoSeattle$15.7M
- Jill JohnsenSeattle$991K
- Fengting YanSeattle$841K
- John PagelSeattle$725K
- Lawrence FongSeattle$546K
- Langdon MillerSeattle$457K
- Mazyar ShadmanSeattle$226K
- Catherine LeeSeattle$199K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.